Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys. (2021)
Attributed to:
MICA: Neuronal Arginine Metabolism in Health and Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2021.09.005
PubMed Identifier: 34703837
Publication URI: http://europepmc.org/abstract/MED/34703837
Type: Journal Article/Review
Volume: 23
Parent Publication: Molecular therapy. Methods & clinical development
ISSN: 2329-0501